The role of vasopressin in treating systemic inflammatory syndrome complicated by right ventricular failure

Cardiology in the Young

Volumn 15, Issue 1, 2005, Pages 88-90

  Vida, Vladimiro L ^a   Mack, Ricardo ^a   Castañeda, Aldo R ^a  

^a Unidad de Cirugia Cardiovascular de Guatemala   (Guatemala)

Author keywords

Congenital heart disease

Indexed keywords

CATECHOLAMINE; INOTROPIC AGENT; VASOPRESSIN; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; CONGENITAL HEART MALFORMATION; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMIC PARAMETERS; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LOADING TEST; LOW DRUG DOSE; POSTOPERATIVE COMPLICATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; DRUG EFFECT; HEART RIGHT VENTRICLE FUNCTION; HEMODYNAMICS; VASCULAR RESISTANCE;

ADULT; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; VASOPRESSINS; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 18244401654     PISSN: 10479511     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1047951105000193     Document Type: Article

References (8)

1. Landry DW, Levin HR, Gallant EM, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997; 25: 1279-1282.
2. Rosenzweig EB, Stare TJ, Chen JM, et al. Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation 1999; 100: II182-II186.
3. Liedel JL, Meadow W, Nachman J, Koogler T, Kahana MD. Use of vasopressin in refractory hypotension in children with vasodilatory shock: five cases and a review of the literature. Crit Care Med 2002; 3: 15-18.
4. Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120: 989-1002.
5. Tsuneyoshi I, Yamada H, Kakihana Y, et al. Hemodynamic and metabolic effects of low-dose vasopressin infusion in vasodilatory septic shock. Crit Care Med 2001; 29: 487-493.
6. Garcia-Villalon AL, Garcia JL, Fernandez N, et al. Regional differences in the arterial response to vasopressin: role of endothelia nitric oxide. Br J Pharmacol 1996; 118: 1848-1854.
7. Evora PR, Pearson PJ, Schaff HV. Arginine vasopressine induced endothelium-dependent vasodilation of the pulmonary artery. V1-receptor-mediated production of nitric oxide. Chest 1993; 103: 1241-1245.
8. Leather HL, Segers P, Berends N, Vandermeersch E, Wouters PF. Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension. Crit Care Med 2002; 30: 2548-2552.